Sophie Pakianather

Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136

Christine Katlama, Marc Antoine Valantin, Michèle Algarté-Génin et al. · AIDS · 2010 · 164 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Improved Survival of HIV-1-Infected Patients with Progressive Multifocal Leukoencephalopathy Receiving Early 5-Drug Combination Antiretroviral Therapy

Jacques Gasnault, Dominique Costagliola, Houria Hendel-Chavez et al. · PLoS ONE · 2011 · 70 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011

Diane Descamps, Lambert Assoumou, Marie‐Laure Chaix et al. · Journal of Antimicrobial Chemotherapy · 2013 · 51 citations · Full text

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +17

Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide study

Lambert Assoumou, Diane Descamps, Sabine Yerly et al. · Journal of Antimicrobial Chemotherapy · 2013 · 45 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Similar Evolution of Cellular HIV-1 DNA Level in Darunavir/Ritonavir Monotherapy versus Triple Therapy in MONOI –ANRS136 Trial over 96 Weeks

Sidonie Lambert-Niclot, Philippe Flandre, Marc‐Antoine Valantin et al. · PLoS ONE · 2012 · 30 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17